The medical technology (Medtech) industry has seen exuberant growth over the past decade, thanks in part to the emergence of alternative investment options. The new funding options available have seen countless new medical technologies enter the market, improving livelihoods and saving lives. Investing in early-stage medical companies in particular has become a much more competitive and democratic process thanks to equity crowdfunding.
Why Invest in Medical Technology?
The UK medical technology industry is a world leader. Companies are sniffing out opportunities and taking advantage of the world class facilities and institutions that are available in the UK, creating industry-leading technologies. In 2013, the UK medical device industry was the sixth biggest in the world, and turnover of the UK medical technology industry has shown a positive growth between 2009 and 2014 (Gov.uk, p. 5).
Medtech companies have been at the vanguard in developing innovative treatments for a wide range of conditions, including cancer and diabetes, as well as new technologies that optimise the way medical procedures are carried out, reducing risk and cost. In addition to the invention of many life-saving devices, investment in medical device technology has led to many UK citizens living longer, healthier and more independent lives.
In December 2016 medtech company Oval Medical Technologies became the inaugural member of SyndicateRoom's Exit Club after being acquired by SMC Ltd. for an undisclosed amount. This news came just two years after Oval's SyndicateRoom raise, which was held in August 2014, raising £1,118,647 from 40 investors. The company used the funding to manufacture a pilot tool for its drug-device combination study.
Why invest with SyndicateRoom?
Our Access EIS fund builds a diversified startup portfolio for you by co-investing with experienced angel investors. It aims to build a portfolio of at least 50 companies for each investor to further mitigate risk, and to replicate annual market growth in the UK startup sector.
What SyndicateRoom offers:
A data-driven approach to venture capital investing that aims to minimise risk.
Access to a larger portion of the startup market through co-investment with experienced business angels.
Generous tax reliefs as part of the EIS scheme for qualifying investors.
Low minimum investment of £5,000.
Join a first-class portfolio
SyndicateRoom is FREE to join
With SyndicateRoom you gain access to invest alongside professional investors receiving the same share class and same share price.